XML 37 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Thousands
Convertible Preferred Stock
Common Stock
IPO
Common Stock
Follow-on Public Offering
Common Stock
Additional Paid-in Capital
IPO
Additional Paid-in Capital
Follow-on Public Offering
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
IPO
Follow-on Public Offering
Total
Beginning Balances at Dec. 31, 2020       $ 1     $ 222 $ (68,220) $ (187)     $ (68,184)
Beginning Balances (in shares) at Dec. 31, 2020       538,793                
Shareholders' Equity                        
Exercise of common stock warrants             34         34
Exercise of common stock warrants (in shares)       198,198,000                
Exercise of common stock options             276         $ 276
Exercise of common stock options (in shares)       321,686               321,686
Equity-based compensation             5,183         $ 5,183
Issuance of Series B-1 convertible preferred stock upon conversion of debt             (397) (14,068)       (14,465)
Conversion of convertible preferred stock into common stock       $ 16     84,745         84,761
Conversion of convertible preferred stock into common stock (in shares)       15,906,537                
Conversion of SAFE into common stock       $ 1     11,177         11,178
Conversion of SAFE into common stock (in shares)       931,485                
Issuance of common stock   $ 4     $ 44,213         $ 44,217    
Issuance of common stock (in shares)   4,333,333                    
Other comprehensive loss                 (11)     (11)
Net loss               (11,716)       (11,716)
Ending Balances at Dec. 31, 2021       $ 22     145,453 (94,004) (198)     51,273
Ending Balances (in shares) at Dec. 31, 2021       22,230,032                
Beginning Balances at Dec. 31, 2020 $ 55,370                      
Beginning Balances (in shares) at Dec. 31, 2020 40,524,346                      
Temporary equity                        
Issuance of Series B-1 Convertible Preferred Stock upon conversion of debt $ 29,391                      
Issuance of Series B-1 Convertible Preferred Stock upon conversion of debt (in shares) 10,926,089                      
Conversion of convertible preferred stock into common stock $ (84,761)                      
Conversion of convertible preferred stock into common stock (in shares) (51,450,435)                      
Exercise of common stock options       $ 2     1,616         $ 1,618
Exercise of common stock options (in shares)       1,761,516               1,761,516
Equity-based compensation             3,572         $ 3,572
Issuance of common stock     $ 5     $ 5,179         $ 5,184  
Issuance of common stock (in shares)     5,000,000                  
Other comprehensive loss                 (1)     (1)
Net loss               (21,397)       (21,397)
Ending Balances at Dec. 31, 2022       $ 29     $ 155,820 $ (115,401) $ (199)     $ 40,249
Ending Balances (in shares) at Dec. 31, 2022       28,991,548